• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: OLYMPUS MEDICAL SYSTEMS CORP. OES CYSTONEPHROFIBERSCOPE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

OLYMPUS MEDICAL SYSTEMS CORP. OES CYSTONEPHROFIBERSCOPE Back to Search Results
Model Number CYF-5
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Unspecified Infection (1930)
Event Date 08/26/2020
Event Type  Injury  
Manufacturer Narrative
The device was returned to olympus and evaluation is pending, as the device was sent to an off-site laboratory for microbiological testing.As part of our investigation into this report, an olympus endoscopy support specialist (ess) was dispatched to the user facility to assess the user facility¿s reprocessing practices, and provide reprocessing training if necessary.On november 13, 2020 an olympus ess visited the user facility to perform a scope reprocessing and infection control in-service for the staff.The ess covered infection control information referenced in the user manual and reprocessing manual.In addition, the ess requested the facility staff to show him each step in the use and reprocessing of the scope.Based on the ess' observation the facility staff was not currently using correct transport bins, not pre-cleaning, not leak-testing after each case, not currently reprocessing stopcock, not currently replacing saline bag or irrigation tubing between each case, not currently reprocessing reusable brushes, not currently soaking scope in detergent for the recommended amount of time, and not currently properly rinsing scope.The ess communicated these findings to the facility staff, and provided them a list recommended proper reprocessing techniques and proper handling and storage of the device.The ess recommended the use of disposable ancillary equipment and to consider using the gluteraldehyde based disinfectant, such as aldahol 1.8.This report will be supplemented when new information becomes available.
 
Event Description
The attending physician reported that there were nine patients that were examined by the same cystoscope.After the procedure, the patients' urine samples were cultured and an esbl e.Coli had been recovered on those patients' urine sample.The patients were treated with antibiotic.The cystoscope was returned to olympus for evaluation to see if there had been any damage on the device.According to the physician, some of the patients have had urine retention, hematuria, septic issues, and uti after the procedures, which triggered him to have the patients' urine be cultured.In addition, it was reported that the device has been manually reprocessed and soaked in cidex opa (disinfectant).The user facility further reported that there had been no device culture performed prior to returning the device to olympus.This is for patient #6 and this is 6 of 9 reports.Cross-reference related reports: (b)(4).
 
Manufacturer Narrative
This supplemental report is being submitted to provide additional information based on the laboratory results and results of device evaluation: based on the laboratory report there was no microorganism recovered from the device.The device was gas sterilized prior to returning the device to olympus.The device instrument channel was examined with the use of a borescope, and found large kinks, stains, and scrape marks in the instrument channel.Additionally, there was a foreign material build-up on the body grip.There was a discoloration of the insertion tube, and more foreign build-up on the bending section cover near the adhesive area.The bending section cover is also torn which caused the device to failed the leak test.There were 16 broken image fibers.A review of the instrument history revealed that the device was purchased on august 21, 2010 with no service events after.This is the first service event for the subject device; the device was refurbished and returned to the user facility.
 
Manufacturer Narrative
This report is being supplemented to provide additional information based on the legal manufacturer's final investigation.A review of the device history record found no deviations that could have caused or contributed to the reported issue.It has been over 13 years since the subject device was manufactured.Based on the results of the investigation, the following causes have been identified: the cause of the positive culture test and suspected cross-contamination was likely from the user deviating from the reprocessing instructions for use.The cause of large kinks, dirt, stains, and scrape marks inside the biopsy channel was likely damaged due to insertion and removal stress of the endotherapy accessories during the procedures.The cause of the foreign build-up on the bending section cover near the glue was likely from inappropriate reprocessing.The cause of the bending section cover torn and leaking was likely from user handling of the device.Olympus will continue to monitor field performance for this device.
 
Manufacturer Narrative
This report is being supplemented to provide additional information from the legal manufacturer's final investigation.A review of the device history record found no deviations that could have caused or contributed to the reported issue.It has been over 14 years since the subject device was manufactured.Based on further investigation findings, although foreign material was confirmed to be adhered to the grip, the specific material could not be identified.In addition, it was also confirmed that dirt was inside the biopsy channel.However, the details about the dirt could not be identified.Both the foreign material and the dirt likely remained due to deviation of reprocessing from the instructions for use (ifu) manual.Furthermore, the root cause of both events could not be determined.The event can be detected/prevented by following the ifu which state: ¿preparation and inspection of the endoscope" instructs user to inspect the appearance of the insertion section and the insertability of the biopsy ch.Based on multiple abnormalities of the subject device confirmed in investigation results 1-4, it is judged that there were deviations from the inspection procedure given in ifu.¿ this supplemental report includes correction to e2, e4, and h4 from initial medwatch.Also, 26aug2020 was inadvertently added to b3 on initial medwatch.This date is incorrect and the event date is unknown.Olympus will continue to monitor field performance for this device.
 
Manufacturer Narrative
Correction to g3 of the initial medwatch.The aware date should be 24-aug-2020.Investigation activities have been opened to manage the actions related to this report and any required mdr reporting.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OES CYSTONEPHROFIBERSCOPE
Type of Device
CYSTONEPHROFIBERSCOPE
Manufacturer (Section D)
OLYMPUS MEDICAL SYSTEMS CORP.
2951 ishikawa-cho
hachioji-shi, tokyo-to 192-8 507
JA  192-8507
Manufacturer Contact
kazutaka matsumoto
2951 ishikawa-cho
hachioji-shi, tokyo-to 192-8-507
JA   192-8507
426425177
MDR Report Key10934579
MDR Text Key219983469
Report Number8010047-2020-09726
Device Sequence Number1
Product Code FAJ
UDI-Device Identifier04953170411144
UDI-Public04953170411144
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K032092
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup,Followup,Followup,Followup
Report Date 12/16/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/02/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberCYF-5
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer08/31/2020
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received12/13/2022
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured06/12/2008
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age66 YR
Patient SexMale
Patient Weight81 KG
-
-